Bristol-Myers Squibb (BMY) Revenue — Quarter Ended Dec 31, 2024
Revenue rose in the current quarter. It grew compared to both the previous quarter and the same quarter one year ago.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue rose in the current quarter. It grew compared to both the previous quarter and the same quarter one year ago.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$12.3B
Revenue reported for this quarter.
Quarter-over-quarter
+3.8%
Change from the immediately preceding quarter.
Year-over-year
+7.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$48.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $11.9B | +4.7% |
| Jun 30, 2024 | $12.2B | +8.7% |
| Sep 30, 2024 | $11.9B | +8.4% |
| Dec 31, 2024 | $12.3B | +7.5% |
Revenue performance
The current quarter's revenue was the highest among the recent quarters.
Quarterly comparison
Sequentially, revenue increased from the prior quarter. On an annual basis, revenue was also higher than the same quarter last year.
What to watch
The revenue improvement over the same period last year was greater than the improvement over the immediately preceding quarter.